TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
UCB Pharma AB (Sweden)
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
156,802
|
141,296
|
145,239 |
Financial expenses |
474
|
329
|
107 |
Earnings before taxes |
8,189
|
6,795
|
7,148 |
EBITDA |
8,184
|
7,011
|
7,220 |
Total assets |
112,885
|
88,300
|
83,802 |
Current assets |
112,885
|
88,300
|
83,802 |
Current liabilities |
70,274
|
47,153
|
39,067 |
Equity capital |
42,611
|
41,146
|
44,735 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
35
|
30
|
31 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
37.7%
|
46.6%
|
53.4% |
Turnover per employee |
4,480
|
4,710
|
4,685 |
Profit as a percentage of turnover |
5.2%
|
4.8%
|
4.9% |
Return on assets (ROA) |
7.7%
|
8.1%
|
8.7% |
Current ratio |
160.6%
|
187.3%
|
214.5% |
Return on equity (ROE) |
19.2%
|
16.5%
|
16.0% |
Change turnover |
14,779
|
7,822
|
7,162 |
Change turnover % |
10%
|
6%
|
5% |
Chg. No. of employees |
5
|
-1
|
5 |
Chg. No. of employees % |
17%
|
-3%
|
19% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.